Typically, the longer a patient with cancer is exposed to a drug the more side effects they experience, but in the case of Imbruvica, the opposite appears to be true for patients with MCL.
Dr. Simon Rule
Advertisement
Articles by Dr. Simon Rule
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
5 Years of Prostate Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
2
FDA Grants Final Approval to OMCAZIO, a New Capsule Formulation of Cabozantinib
3
What Your Friend with Cancer REALLY Needs
4
5 Years of Lung Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
5